NCT04403633 A Study of Facilitators and Barriers to Improve Acute Kidney Injury in Children Through Mobile Health Intervention
| NCT ID | NCT04403633 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Acute Kidney Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2020-06-01 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2020-06-01 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to improve patient-centered care for acute kidney injury (AKI) in order to decrease the adverse health outcomes associated with this common condition.
Eligibility Criteria
Inclusion Criteria: * age 1 to 18 years * patients with diagnosis of AKI while hospitalized Exclusion Criteria: * legal blindness of deafness * cognitive impairment that limits ability to consent * non-English speaking * patient age greater than age 18 years, 11 months
Contact & Investigator
Clarissa J Diamantidis, MD
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT04403633 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 18 Years, studying Acute Kidney Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04403633 currently recruiting?
Yes, NCT04403633 is actively recruiting participants. Contact the research team at anna.e.williams@duke.edu for enrollment information.
Where is the NCT04403633 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT04403633 clinical trial?
NCT04403633 is sponsored by Duke University. The principal investigator is Clarissa J Diamantidis, MD at Duke University. The trial plans to enroll 25 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.